Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 6/20 | 0.35 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13427225 | 1.00 | P2RX4 (0.35) | P2RX4P2RX1P2RX3MAPTSMN1; SMN2 | |
| SCHEMBL13009404 | 0.97 | P2RX4 (0.33) | P2RX4 | |
| SCHEMBL13008897 | 0.97 | P2RX4 (0.33) | P2RX4 | |
| SCHEMBL13008899 | 0.91 | FAAH (0.36) | P2RX4 | |
| SCHEMBL13427265 | 0.91 | GPR84 (0.33) | P2RX4 | |
| SCHEMBL13008893 | 0.90 | FAAH (0.35) | P2RX4 | |
| SCHEMBL13428275 | 0.89 | SMN1; SMN2 (0.33) | MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13008905 | 0.89 | ESR1 (0.37) | MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13427255 | 0.89 | SMN1; SMN2 (0.33) | MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13008294 | 0.88 | MGLL (0.33) | P2RX4NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | P2RX4 2539/4885P2RX1 2098/4885P2RX3 2290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.